Join the Conversation


Moment of Truth.

Last month, one of the world’s largest pharmaceutical companies enlisted Fusion Hill to conduct research with physicians and consumers to understand the journey in treating Fibromyalgia (FM), a syndrome in which a person has chronic pain and tenderness throughout the body, and Diabetic Peripheral Neuropathy (DPN), nerve damage caused by diabetes and high blood sugar.

Treating FM and DPN patients has proved to be complex and tiring – patients depressed about their health status, doctors skeptical about judging pain level, and of course the kicker – there is no cure. Medication for FM and DPN does not cure the patient but is a symptomatic treatment that helps manage the condition. At what point do physicians abandon a non-pharmaceutical treatment approach – healthy diet, exercise, sleep – and decide that prescription medication is needed? When do patients decide that they even want medication? When is their moment of truth? What are the gaps in communication that result in patients being under-prescribed and what tools/resources could close those patient-physician gaps.

| Research

Get In Touch

1414 Marshall Street NE
Minneapolis, MN 55413
612 638 5000


If you share our passion for integrated problem solving and developing remarkable creative solutions, we’d love to hear from you. Visit our careers page to view openings.


WBE1802360 WOSB181678

Fusion Hill

Privacy Policy


Sign up for our newsletter or follow us on social media: